By blocking VEGFR-mediated signaling, VEGF inhibitors can disrupt vascular homeostasis and endothelial function, increasing vascular permeability and potentially leading to leakage of fluid into the interstitial and cerebral spaces. This can culminate in vasogenic edema, a hallmark of PRES. Here, VEGFA is linked to Posterior Leukoencephalopathy Syndrome.